Correlation Between Cann American and Nexien Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cann American and Nexien Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cann American and Nexien Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cann American Corp and Nexien Biopharma, you can compare the effects of market volatilities on Cann American and Nexien Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cann American with a short position of Nexien Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cann American and Nexien Biopharma.

Diversification Opportunities for Cann American and Nexien Biopharma

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Cann and Nexien is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Cann American Corp and Nexien Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexien Biopharma and Cann American is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cann American Corp are associated (or correlated) with Nexien Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexien Biopharma has no effect on the direction of Cann American i.e., Cann American and Nexien Biopharma go up and down completely randomly.

Pair Corralation between Cann American and Nexien Biopharma

Given the investment horizon of 90 days Cann American is expected to generate 1.52 times less return on investment than Nexien Biopharma. But when comparing it to its historical volatility, Cann American Corp is 1.19 times less risky than Nexien Biopharma. It trades about 0.08 of its potential returns per unit of risk. Nexien Biopharma is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  2.70  in Nexien Biopharma on September 4, 2024 and sell it today you would lose (1.30) from holding Nexien Biopharma or give up 48.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.19%
ValuesDaily Returns

Cann American Corp  vs.  Nexien Biopharma

 Performance 
       Timeline  
Cann American Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cann American Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Cann American sustained solid returns over the last few months and may actually be approaching a breakup point.
Nexien Biopharma 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nexien Biopharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Nexien Biopharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Cann American and Nexien Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cann American and Nexien Biopharma

The main advantage of trading using opposite Cann American and Nexien Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cann American position performs unexpectedly, Nexien Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexien Biopharma will offset losses from the drop in Nexien Biopharma's long position.
The idea behind Cann American Corp and Nexien Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio